{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:11:09Z","timestamp":1790104269957,"version":"4.0.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:title>\n                    <jats:bold>ABSTRACT<\/jats:bold>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Clostridium difficile<\/jats:italic>\n                      infections can be life-threatening but are increasingly being treated successfully with fecal microbiota transplantation (FMT). We report two patients with alopecia universalis who developed subsequent hair regrowth after FMT for treatment of recurrent\n                      <jats:italic toggle=\"yes\">C. difficile<\/jats:italic>\n                      infections. Gut microbiota may have immunomodulatory effects in autoimmune conditions such as alopecia areata, and further study may elucidate disease mechanisms and lead to alternative treatment options for these patients for whom treatment options are currently limited.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.14309\/crj.2017.107","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T15:46:19Z","timestamp":1505317579000},"page":"e107","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":103,"title":["Hair Growth in Two Alopecia Patients after Fecal Microbiota Transplant"],"prefix":"10.14309","volume":"4","author":[{"given":"Dionne","family":"Rebello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Lio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen R.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-107-20260710","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","article-title":"Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis.","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"R2-107-20260710","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.cell.2017.01.022","article-title":"Mining the human gut microbiota for immunomodulatory organisms.","volume":"168","author":"Geva-Zatorsky","year":"2017","journal-title":"Cell"},{"key":"R3-107-20260710","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/eji.201242741","article-title":"Human Th17 subsets.","volume":"42","author":"Sallusto","year":"2012","journal-title":"Eur J Immunol"},{"key":"R4-107-20260710","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000353159","article-title":"Comparison of interleukin-17-producing cells in different clinical types of alopecia areata.","volume":"227","author":"Tojo","year":"2013","journal-title":"Dermatology"},{"key":"R5-107-20260710","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1346-8138.12740","article-title":"Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.","volume":"42","author":"Avitabile","year":"2015","journal-title":"J Dermatol"},{"issue":"1","key":"R6-107-20260710","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2016.10.004","article-title":"Alopecia areata: Whats new in epidemiology, pathogenesis, diagnosis, and therapeutic options?","volume":"86","author":"Dainichi","year":"2017","journal-title":"J Dermatol Sci"},{"key":"R7-107-20260710","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohns disease.","volume":"375","author":"Feagan","year":"2016","journal-title":"N Engl J Med"},{"key":"R8-107-20260710","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/ni0111-5","article-title":"Diet, gut microbiota, and immune responses.","volume":"12","author":"Maslowski","year":"2011","journal-title":"Nat Immunol"},{"issue":"6","key":"R9-107-20260710","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1572-0241.2005.41641.x","article-title":"Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura: A randomized controlled trial.","volume":"100","author":"Suzuki","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R10-107-20260710","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11894-013-0337-1","article-title":"Fecal microbiota transplantation: Indications, methods, evidence and future directions.","volume":"15","author":"Borody","year":"2013","journal-title":"G Curr Gastroenterol Rep"},{"issue":"6032","key":"R11-107-20260710","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.1206095","article-title":"The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.","volume":"332","author":"Round","year":"2011","journal-title":"Science"},{"key":"R13-107-20260710","first-page":"19","article-title":"Fecal transplant eases symptoms of Parkinsons.","volume":"2796","author":"Anathaswamy","year":"2011","journal-title":"New Scientist Issue"},{"issue":"Suppl 1","key":"R14-107-20260710","doi-asserted-by":"crossref","first-page":"S591","DOI":"10.14309\/00000434-201210001-01481","article-title":"Bacteriotherapy in chronic fatigue syndrome: A retrospective sreview.","volume":"107","author":"Borody","year":"2012","journal-title":"Am J Gastroenterol"}],"container-title":["ACG Case Reports Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02075970-201704000-00107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:19:58Z","timestamp":1786547998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02075970-201704000-00107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.14309\/crj.2017.107","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.731254308.793546375","asserted-by":"object"}]},"ISSN":["2326-3253"],"issn-type":[{"value":"2326-3253","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}